About Cime Therapeutics
Cime Therapeutics is a private company based in Denver, Colorado, incorporated in 2024 in Delaware. It has reported $2,100,000 raised in one offering on Form D since March 2025. Its chief executive is James Brewster II.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 14, 2025 | Mar 21, 2025 | $2,100,000of $2.5M target | 3 | $700K | OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cime Therapeutics's Form D filed Mar 21, 2025.
JI
James Brewster II
Chief Executive Officer and director
CE
Chris Erickson
Director